This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides FDA to Convene Pharmacy Compounding Advisory Committee in July FDA to Review 7 Peptides for Compounding List in July 2026: BPC 157, Semax, Epitalon, and More HealingMaps FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner Peptides are starting to move back into the conversation., After years of restriction under the FDAs 503A Category 2 list, were now seeing momentum toward re evaluation and potential reintroduction FDA Peptide Transparency Scandal 2026: Who's Really Controlling BPC 157, TB 500 & More? YouTube